Lacosamide Induced Psychosis. Issue 5 (September 2015)

• Record Type: Journal Article
• Authors: Pinkhasov, Aaron; Lam, Timothy; Hayes, Dillon; Friedman, Michelle; Singh, Deepan; Cohen, Henry
• Is Part Of: Clinical neuropharmacology. Volume 38:Issue 5(2015)
• Publication Date: 2015-09
• Subjects: Neuropharmacology -- Periodicals; 615.78
• DOI: 10.1097/WNF.0000000000000097
• Languages: English
• ISSNs: 0362-5664

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Abstract</title> <p>Lacosamide (LCM) is an antiepileptic medication used as an adjunctive treatment for partial seizures. Psychosis associated with LCM use is a rarely documented phenomenon, which may be difficult to detect in the context of the often complicated clinical presentation of epilepsy. We report the development of psychosis in a young woman after the use of LCM, which subsequently resolved with its discontinuation. The possible differential diagnosis and pharmacokinetic nuances are discussed. This is the first case report of LCM-induced psychosis in the United States.</p> </sec> </abstract>